Viatris Inc.
Viatris Inc. (VTRS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VTRS · as of Jun 8, 2026
Key Statistics
Explore Viatris Inc. Data
vtrs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 30.8%
The VTRS analyst consensus is Hold, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $17.40, representing +8.82% upside from the current price of $15.99.
Competitors & Peers
vtrs competitorsVTRS
BAX
BBIO
ELAN
EXAS
IONSStock Performance
Full HistoryAbout Viatris Inc.
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generi…
what is viatris inc. · vtrs stock overview · viatris inc. company profile · who is viatris inc. ceo · vtrs NASDAQ · viatris inc. headquarters · viatris inc. business segments
About Stock Overview & Key Data
Viatris Inc. (VTRS) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Mar 17, 1980. As of the latest trading session, VTRS stock price is $15.99, with a market capitalization of $18.6B. The stock has returned +81.53% over the past 12 months and +28.46% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Viatris Inc. stock is Hold, with an average 12-month price target of $17.40. In fiscal year 2025, Viatris Inc. reported revenue of $14.3B and net income of -$3.5B. For detailed data — including Viatris Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Viatris Inc. (VTRS) stock price is $15.99. The stock is traded on NASDAQ under the ticker symbol VTRS. The 52-week range is $8.44 – $17.53.